FUB-PB-22 , 3-carboxyindole metabolite is an analytical reference material that is structurally classified as a synthetic cannabinoid. It is a presumptive metabolite of FUB-PB-22 (Item No. 14949). The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.
FUB-PB-22 and all other synthetic product cannabinoids sold on this website are for research and legal applications. A chemical study called FUB-PB-22 is a designer drug with obvious physiological and psychoactive effects and has the molecular formula C25H17FN2O2. The weight of the formula has a cost of 396.4 g / molecular weight. Side effects of FUB-PB-22 are not known.
Synthetic product of cannabinoids like FUB-PB-22 might show a high attraction to peripheral CB1 and CB2 cannabinoid receptors.
Full chemical name: quinolin-8-yl-1- (4-fluorobenzyl) -1H-indole-3-carboxylate.
Keep this synthetic product cannabinoid in a cool and dry place. The stability of cannabinoid is FUB-PB-22 up to 2 years under proper storage conditions. We successfully synthesized 5 carboxylate
SCRAs using established synthetic and analytical chemistry methodologies. We identified at least 1 SCRA in samples from 49 patients, including an indole or indazole carboxylate SCRA in 17 (35%), specifically 5F-PB-22 (14%), FUB PB-22 (6%), BB-22 (2%), 5F NPB-22(20%), FUB NPB-22 (2%), and 5F-SDB-005 (4%). In these 17 patients, there was analytical evidence of other substances in 16. Clinical features included agitation and aggression (82%), reduced consciousness (76%), acidosis.